This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
| INTRODUC TI ON
Spanning over 15 years, approximately 50% of koalas admitted to South East Queensland (SEQLD) wildlife hospitals have presented with chlamydiosis, frequently in combination with trauma and body wasting (Gonzalez-Astudillo, Allavena, McKinnon, Larkin, & Henning, 2017) . The obligate intracellular bacteria Chlamydia pecorum is the most pathogenic and prevalent bacteria affecting koalas (Devereaux, Polkinghorne, Meijer, & Timms, 2003; Jackson, White, Giffard, & Timms, 1999; Marsh, Kollipara, Timms, & Polkinghorne, 2011) and infects the ocular, urinary, and genital mucosae with acute and/or persistent exposure to infection resulting in blindness, cystitis, and infertility (Blanshard & Bodley, 2008; Wan et al., 2011) . Not all infections manifest in overt disease, and approximately half the koalas in SE Queensland appear to be healthy carriers of C. pecorum and do not exhibit any signs of disease . Diagnosis of chlamydial disease in koalas has been by a combination of visual assessment of clinical signs of disease, ultrasonography of the koala urogenital tract, and, up until recently, a diagnostic point-of-care (POC) solid-phase enzyme immunoassay for detection of Chlamydia lipopolysaccharide antigen (Clearview®); however, this product is no longer commercially available. In addition, Hanger et al. (2013) showed that Clearview was only 43.2% sensitive and 92% specific compared with C. pecorum detection via qPCR, indicating that a Clearview result lacked specificity and sensitivity. With production of Clearview® ceasing, there is currently no alternative POC method for detection of C. pecorum infection in koalas available to wildlife hospitals, and consequently, there has been an increasing reliance on external diagnostic laboratories for confirmation of infection via molecular detection incorporating nucleic acid amplification tests such as conventional and real-time PCR (Hulse et al., 2018; Sachse et al., 2009) .
Polymerase chain reaction (PCR) is considered the "gold standard" diagnostic assay of choice for detection of Chlamydia based on its reliability and high sensitivity and specificity. However, a key disadvantage of PCR-based methods has been the restriction of its use to research and/or diagnostic laboratories to undertake sample processing and time-consuming thermocycling protocols, which can delay diagnosis and subsequent treatment by 24-48 hr. This means that infection status of koalas is not available to veterinarians and koala carers until well after initial decisions on animal management have been determined, leading to delays for application of animal therapeutic treatment regimes.
Molecular diagnostic tools that can be performed at POC have been developed incorporating loop-mediated isothermal amplification (LAMP), a newly developed, simple yet sophisticated, gene amplification method (Notomi, Mori, Tomita, & Kanda, 2015) . The key advantage of LAMP is that it is a simple and rapid protocol, which means "on-the-spot" pathogen diagnosis is possible. It offers high sensitivity and specificity even when there is a decreased amount of target DNA available (Notomi et al., 2000) . Using LAMP, the target sequence is amplified at a constant temperature of 60-65°C (no cycling required) using multiple sets of primers and a polymerase with high strand displacement activity in addition to a replication activity.
Typically, four different primers are used to identify six distinct regions on the target gene, which adds highly to the specificity. An additional pair of "loop primers" further accelerates the reaction. Due to the specific nature of the action of these primers, the amount of DNA produced using LAMP is considerably higher than PCR-based amplification, meaning results are available in less than an hour. As confirmation of amplification of the correct target, an anneal step, consisting of 98-80ºC at 0.01ºC/s resulting in an anneal temperature of the amplicon produced, is performed after the isothermal step. Each target will have its own signature anneal temperature which is determined by the GC content of the generated amplicon.
Positive amplification followed by an anneal temperature at the expected temperature is confirmation of a true positive in a sample.
The Genie ® III (OptiGene Limited) is a compact, portable, batteryoperated device for isothermal amplification and real-time fluorescence detection at the POC. LAMP assays performed on the Genie ® III provide a rapid diagnostic tool with high specificity, due to the multiple primer sets; high sensitivity; all with minimal sample template preparation, which allows for easy incorporation as a diagnostic tool within the field or wildlife hospital, as previously reported by Jelocnik et al. (2017) .
In the present study, we describe the development and validation of a C. pecorum-specific LAMP assay on the Genie ® III using conjunctival, urogenital, and rectal koala swabs, aimed at POC pathogen detection by wildlife hospital veterinary clinicians and koala ecologists in the field.
| MATERIAL S AND ME THODS

| Sample template preparation
Duplicate conjunctiva, urogenital sinus (females) or penile urethra (males), and rectal samples were collected from koalas admitted to Currumbin Wildlife Hospital (Currumbin, Queensland) and Australia Zoo Wildlife Hospital (Beerwah, Queensland) using rayon-tipped aluminum-shafted swabs (Copan, Murrieta, California). Opportunistic sampling of koalas admitted to wildlife hospitals included animals exhibiting clinical signs of disease and symptoms unrelated to infectious disease (e.g., trauma, ill thrift, poor body condition).
Two crude DNA lysing methods to isolate DNA template from patient swabs were evaluated, as recommended by Optigene LAMP user guide for Mastermixes and assay optimization. The first method consisted of a two-step lysis procedure, whereby 0.2 ml of nuclease free water was added to a swab in a 2-ml microtube followed by vigorous mixing. A 50 µl aliquot was then heated to 95°C for 5 min to disrupt cell membranes and release cell contents into the buffer.
A second method consisted of a crude one-step lysis method for the LAMP assay by the addition of 0.2 ml alkaline solution (potassium hydroxide, KOH) to a swab in a 2-ml microtube followed by vigorous mixing. The addition of KOH to the swab enables destruction of the cell wall of any bacteria or host cells present, releasing the cell contents, including bacterial DNA into the lysis buffer. Table A1 ) (Blanshard, 1994; Blanshard & Bodley, 2008) . Bacterial genomic DNA was extracted from isolates using the DNeasy Blood & Tissue Kit (QIAGEN Inc) according to manufacturer's instructions. In addition, DNA was isolated from quantified (inclusion-forming units; IFU/ml) reference C. pecorum strain culture and used as a positive control for the development and optimization of the LAMP assay. Assay sensitivity and limit of detection were determined by constructing a standard curve in the range of 4.39 × 10 1 -10 7 (44-43,900,000 IFU/mL) using genomic DNA extracted from C. pecorum culture purified and quantified as described in Caldwell, Kromhout, and Schachter (1981) . Intraspecies specificity of the target sequence was confirmed using the Basic Local Alignment Search Tool (BLAST) on the National Center for Biotechnology Information (NCBI) server (http://www. ncbi.nlm.nih.gov/) and Geneious Prime 2019.1.3. Primers were synthesized by Integrated DNA Technologies. Table 1 provides 
| Bacterial strains and DNA preparation
| LAMP primer design
| LAMP reaction and amplification condition
To make a comparative analysis and establish specificity of the LAMP assay by comparing amplification results with qPCR, published primers for two independent qPCR assays that targeted C.
pecorum OmpA and OmpB gene sequences (Table 1) 
| RE SULTS
| Evaluation of sample template preparation
Comparison of sample template preparation revealed the heating method did not appear to sufficiently lyse the template, whereby no amplification of product occurred from samples confirmed positive via real-time PCR results. Establishing that the first method of sample template preparation was unsuccessful, the second method of sample template preparation was applied for the remainder of the study. The addition of KOH to swab samples sufficiently released template DNA into the buffer prior to LAMP testing, confirmed by comparison with real-time PCR results of the duplicate sample. Table 3 presents the time to amplification of the C. pecorum standard curve and corresponding melt temperature. Linear regression of the standard curve determined the LAMP assay level of detection, established at 44 C. pecorum IFU/ml and amplifying in less than 20 min. 
| Chlamydia pecorum limit of detection-Sensitivity
| Comparative specificity of C. pecorum LAMP Assay
Specificity of the C. pecorum LAMP assay was demonstrated by amplification only occurring in DNA extracted from the C. pecorum isolate with no cross-hybridization with nontarget bacterial DNA (Table   A1 ). A total of 43 DNA extracts from clinical samples were tested with two C. pecorum qPCR assays, each targeting different genes, and compared with LAMP assay results from the corresponding duplicate clinical swab, whereby sample template was prepared by the addition of KOH to the swab. comparison with LAMP assay time to amplification with real-time PCR amplification cycling threshold for both qPCR assays. Rhodes et al. (2011) have suggested that chlamydial infection and disease, predominately attributed to C. pecorum, is a key agent of population decline of koalas in SEQLD. Previously, POC tests for identification of C. pecorum infections in koalas have relied on the Clearview® Chlamydia Antigen test, despite the poor sensitivity of the test as reported by Hanger et al. (2013) . Thus, identification of C. pecorum infection in the koala is now predominately determined by nucleic acid amplification tests (e.g., Hulse et al., 2018) . However, the use of these assays, which are highly sensitive and specific to the target pathogen, is generally restricted to research and diagnostic laboratories, a process that can be time-consuming and present delays to the veterinary clini- In this study, we describe the design of a LAMP assay for the rapid detection of C. pecorum on a Genie ® III and the evaluation of its performance against koala clinical samples and nontarget pathogens as a POC application. This study has shown that the C.
| D ISCUSS I ON
pecorum LAMP assay is 100% sensitive and specific in detecting C. pecorum infection from koala clinical swab samples, when compared to the real-time PCR assays, with a level of detection at 44 C. pecorum IFU/ml. While it is uncommon for a diagnostic assay to be 100% sensitive and specific compared with the gold standard method, it is highly likely that if there was more than one sample type being evaluated, there would be lower correlation between tests. However, this study evaluated the standard sample type collected from koalas for molecular detection of Chlamydia sp. within wildlife hospitals.
LAMP has successfully been used to diagnose various pathogens and viruses in humans and animals (Dhama et al., 2014) , and due to its simplicity, robustness, and low cost, LAMP can be used as a simple screening assay in the field or at the point of care by clinicians. The methodology outlined in this study has already been success- 
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